Describe your treatment recommendations, including the type of treatment modality and whether or not you would refer the client to a medical provider for psychotropic medications..
Describe your treatment recommendations, including the type of treatment modality and whether or not you would refer the client to a medical provider for psychotropic medications..
July 10, 2020 Comments Off on Describe your treatment recommendations, including the type of treatment modality and whether or not you would refer the client to a medical provider for psychotropic medications.. Uncategorized Assignment-helpPEER 1Danielle Richbow wk6 CollapseDiagnosis296.22 (F32.1) Major depressive disorder – ModerateV61.10 (Z63.0) Relationship Distress with Spouse or Intimate PartnerV61.03 (Z63.5) Disruption of Family by Separation or DivorceExplanation of DiagnosisFor Sophia she fits the symptoms of major depressive disorder. During her interview she showed signs of feeling down, fearful, Sophia’s wife has expressed that Sophia has become very agitated and would sometimes punch the wall, and that Sophia would not get out of bed and would not be able to focus at work. Viewing the criteria she has at least 5 of the symptoms for criteria A, meets criteria B which caused Sophia to sometimes not be able to do her job as well and created issues at home. She also meets criteria C as she reports only being a social drinker but her wife believes that she maybe on drugs.Sophia also has relationship issues with both her wife and her children as she has found herself talking a lot and her wife and children not being able to get a world in. The start of the case she expressed that her wife would only stay with her if she got treatment. The disruption of the separation has her feeling like she does not want to live without her family. The hope is that if she gets treatment, then they will be able to stay together.Evidenced-Based measurement toolOne tool that would be helpful in diagnosis Sophia and the severity of the major depressive disorder is that Adult PROMIS emotional distress short from in the cross-cutting symptoms measure (APA, 2013). This would allow the clinician to get an understanding of her symptoms and track her progress over time. Another benefit of this test would be to see if Sophia worry is something that should be looked at for an anxiety disorder.Treatment RecommendationsFor treatment I would recommend face-to-face Cognitive Behavioral Therapy (CBT) for Sophia. This form of therapy has shown to be effective for individuals in her age range and with the severity of her symptoms (Whiston, Bockting & Semkovsak, 2019). There also are results showing that this would be better in an individual therapy setting as apposed to a group setting (Whiston et el, 2019). Studies have also shown that there is a greater outcome if there is no Anti-depression Medication added to the treatment plan (Whiston et el, 2019).ReferencesAmerican Psychiatric Association. (2013b). Cross-cutting Symptoms Measure. In Diagnostic Statistical Manual of Mental Disorders (5th ed.) Arlington, VA: Author.Whiston, A., Bockting, C. L. H., & Semkovska, M. (2019). Towards personalising treatment: A systematic review and meta-analysis of face-to-face efficacy moderators of cognitive-behavioral therapy and interpersonal psychotherapy for major depressive disorder. Psychological Mediapeer2Carratta Powell Discussion 1 – Week 6-Carratta Powell COLLAPSEF31.9 Unspecified bipolar and related Disorder , moderate to Severe, Depressive episode with mixed features.Z63.0 Relationship distress with Z63.8 High express emotion within familyDepressive episode, with mixed features: Sofia would not get out of bed or go to work because she said she could not concentrate on work, she was feeling so bad. Elevated, expansive mood. 2. Inflated self-esteem or grandiosity. Her focus was on advancing her career and she believed she could get into management in a short period of time.3. More talkative than usual or pressure to keep talking. Her wife and the children could not get a word in edgewise though. Sofia has been feeling really good is having an elevated expansive mood “on top of the world” (The case of Sofia). This feeling lasts a few days. She then would have angry outbursts and act out and punch the wall. Sofia reports she is concerned about her concentration since she is so worried about her wife leaving with the children1. During the interview, Sofia talked fast. She indicated this is because she feels tense but this is not unusual for her. Sofia reports she is very generous with her family and buys a lot of gifts, which everyone appreciates, even though her wife sometimes complains about it. Increased or excessive involvement in activities that have a high potential. She also has a decreased need for sleep. She needs to sleep to get to work but a few hours of sleep do not seem to affect her. Her work is not affected by this behavior. I believe that symptoms, Mixed features came from Sophia lying bed and not getting out and feeling on top of the world at the same time. Recommend a specific evidence-based measurement instrument to validate the diagnosis and assess outcomes of treatmentThe Mood Disorder Questionnaire (MDQ) is an excellent screening tool for bipolar disorder. It is considered a gold standard screening tool in the world of bipolar disorder. (Jain, et.al., 2017) Even though treatment guidelines around the world recommend the use of measurement-based care, a shortcoming in our field is the lack of in-depth knowledge about what this instrument is, how to interpret scores, and how to utilize the MDQ in everyday clinical practice (Jain, et.al., 2017) The MDQ is a brief self-report instrument that screens for a lifetime history of manic or hypomanic symptoms.21 The MDQ includes 13 yes/no questions to determine the presence of manic/hypomanic symptoms, as well as questions to determine the timing of their occurrence and any impairment associated with the symptoms.Describe your treatment recommendations, including the type of treatment modality and whether or not you would refer the client to a medical provider for psychotropic medications.


